Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-22-133843
Filing Date
2022-04-29
Accepted
2022-04-29 16:20:07
Documents
16
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d331465d10ka.htm   iXBRL 10-K/A 432710
2 EX-31.1 d331465dex311.htm EX-31.1 7025
3 EX-31.2 d331465dex312.htm EX-31.2 6940
  Complete submission text file 0001193125-22-133843.txt   679802

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA orgo-20211231.xsd EX-101.SCH 4682
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orgo-20211231_cal.xml EX-101.CAL 675
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orgo-20211231_def.xml EX-101.DEF 1680
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE orgo-20211231_lab.xml EX-101.LAB 21044
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orgo-20211231_pre.xml EX-101.PRE 17018
10 EXTRACTED XBRL INSTANCE DOCUMENT d331465d10ka_htm.xml XML 6391
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37906 | Film No.: 22875804
SIC: 2834 Pharmaceutical Preparations